tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market

CStone Pharmaceuticals (2616) Cash flow

Compare
4 Followers

CStone Pharmaceuticals Cash Flow

HK:2616's free cash flow for Q2 2025 was ¥0.00. For the 2025 fiscal year, HK:2616's free cash flow was decreased by ¥310.71M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ -343.18M¥ -588.84M¥ -612.47M¥ -1.48B¥ -508.07M
Investing Cash Flow
¥ -247.68M¥ 619.61M¥ 365.12M¥ -826.55M¥ 1.18B
Financing Cash Flow
¥ -12.90M¥ 388.36M¥ 28.47M¥ 92.30M¥ 1.39B
End Cash Position
¥ 387.94M¥ 996.67M¥ 558.68M¥ 742.72M¥ 3.02B
Free Cash Flow
¥ -343.18M¥ -653.89M¥ -714.29M¥ -1.63B¥ -579.52M
Currency in CNY

CStone Pharmaceuticals Cash Flow